Your browser doesn't support javascript.
loading
Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration.
Khanna, Astha; Ayan, Bugra; Undieh, Ada A; Yang, Yunzhi P; Huang, Ngan F.
Affiliation
  • Khanna A; Graver Technologies, Newark, NJ 07105, USA.
  • Ayan B; Department of Cardiothoracic Surgery, Stanford University, Stanford, CA 94305, USA; Stanford Cardiovascular Institute, Stanford University, Stanford, CA 94305, USA.
  • Undieh AA; Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.
  • Yang YP; Department of Orthopedic Surgery, Stanford University, Stanford, CA 94304, USA; Department of Materials and Science, Stanford University, Stanford, CA 94305, USA; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
  • Huang NF; Department of Cardiothoracic Surgery, Stanford University, Stanford, CA 94305, USA; Stanford Cardiovascular Institute, Stanford University, Stanford, CA 94305, USA; Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA; Center for Tissue Regeneration, Veterans Affairs Palo
J Mol Cell Cardiol ; 169: 13-27, 2022 08.
Article in En | MEDLINE | ID: mdl-35569213
Three-dimensional (3D) bioprinting of cellular or biological components are an emerging field to develop tissue structures that mimic the spatial, mechanochemical and temporal characteristics of cardiovascular tissues. 3D multi-cellular and multi-domain organotypic biological constructs can better recapitulate in vivo physiology and can be utilized in a variety of applications. Such applications include in vitro cellular studies, high-throughput drug screening, disease modeling, biocompatibility analysis, drug testing and regenerative medicine. A major challenge of 3D bioprinting strategies is the inability of matrix molecules to reconstitute the complexity of the extracellular matrix and the intrinsic cellular morphologies and functions. An important factor is the inclusion of a vascular network to facilitate oxygen and nutrient perfusion in scalable and patterned 3D bioprinted tissues to promote cell viability and functionality. In this review, we summarize the new generation of 3D bioprinting techniques, the kinds of bioinks and printing materials employed for 3D bioprinting, along with the current state-of-the-art in engineered cardiovascular tissue models. We also highlight the translational applications of 3D bioprinting in engineering the myocardium cardiac valves, and vascular grafts. Finally, we discuss current challenges and perspectives of designing effective 3D bioprinted constructs with native vasculature, architecture and functionality for clinical translation and cardiovascular regeneration.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Engineering / Bioprinting Type of study: Prognostic_studies Language: En Journal: J Mol Cell Cardiol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Engineering / Bioprinting Type of study: Prognostic_studies Language: En Journal: J Mol Cell Cardiol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom